Both in Biotechnology
Entera Bio vs REGENXBIO
Over the past year ENTX returned +10.6% and RGNX returned −35.4%; their daily moves had a correlation of 0.09.
ENTX +10.6% RGNX −35.4%Growth of $1, one year, split-adjusted
| Metric | ENTX | RGNX |
|---|---|---|
| Price | $3.14 | $7.75 |
| Market cap | $546.1M | $511.3M |
| Today | +2.95% | +1.51% |
| 1 month | +24.1% | +4.0% |
| 6 months | +151.2% | −24.2% |
| Year to date | +61.9% | −46.2% |
| 1 year | +10.6% | −35.4% |
| Revenue growth (YoY) | — | +405.7% |
| Gross margin | — | 99.0% |
| Net margin | — | 21.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.9× |
| Net cash | $11.0M | $105.5M |
| Dividend yield | — | — |
| Volatility (60d) | 61.4% | 87.0% |
| Short % of float | 3.5% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).